| Alan C. Cheng earned undergraduate degrees in Electrical Engineering & Computer Science and Molecular Cell Biology at UC Berkeley. He went on to complete his Ph.D. in Biophysics at UC San Francisco, where he studied protein-RNA interactions in the lab of Alan Frankel. Following his graduate studies, Alan joined Pfizer Global R&D, where he was involved in computer-aided drug design and target assessment. He eventually led small teams in computational target assessment and the identification of novel allosteric kinase inhibitors. He joined Amgen in mid-2006, where he is currently engaged in discovering new medicines for oncology and neuroscience diseases, primarily working with chemists and biologists in computer-aided design of small molecule therapeutics. At Brandeis University, Alan co-teaches graduate courses on structural bioinformatics and macromolecular biophysics for the Bioinformatics M.S. degree program. He has authored or co-authored a number of papers on structural bioinformatics and small-molecule drug design. |